Inoue M, Kojima M, Aikoh H, Sugai K, Murakami N, Nonaka I, Hayasaka K, Yamamoto M, Sobue G
Department of Pediatrics, Yamada Red Cross Hospital, Mie.
No To Hattatsu. 1999 Sep;31(5):452-7.
Charcot-Marie-Tooth disease type 1A (CMT1A) is an autosomal dominant demyelinating peripheral neuropathy. Most patients with CMT1A including sporadic cases have been found to have a 1.5 megabase tandem DNA duplication in chromosome 17 p11.2-p12 (CMT1A duplication). We reported a 7-year-old girl with sporadic CMT 1 associated with the CMT1A duplication. The diagnosis of CMT 1 was based on the symmetrical distal muscle weakness, per cavus deformity, reduced motor and sensory nerve conduction velocities, and segmental de- and remyelinatin on sural nerve biopsy. To detect the CMT 1A duplication, peripheral myelin protein 22 (PMP-22) cDNA and a polymorphic marker in this region, VAW409 R3, were employed as probes for Southern blot analysis. Sporadic cases of autosomal dominant-CMT type 1 can not be clinically differentiated from recessive-CMT1. Testing for the CMT1A duplication is an important first step even in the molecular diagnosis of sporadic CMT1.
1型遗传性运动感觉神经病(CMT1A)是一种常染色体显性脱髓鞘性周围神经病。多数CMT1A患者(包括散发病例)被发现其17号染色体p11.2 - p12区域存在1.5兆碱基的串联DNA重复(CMT1A重复)。我们报告了一名7岁散发型CMT1A相关的女童。CMT1的诊断依据为双侧远端肌无力、高弓足畸形、运动和感觉神经传导速度降低以及腓肠神经活检显示节段性脱髓鞘和髓鞘再生。为检测CMT1A重复,外周髓鞘蛋白22(PMP - 22)cDNA及该区域的一个多态性标记VAW409 R3被用作Southern印迹分析的探针。常染色体显性1型CMT散发病例在临床上无法与隐性CMT1相鉴别。即使在散发性CMT1的分子诊断中,检测CMT1A重复也是重要的第一步。